These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 30816330)
1. The role of TGFβ in hematopoiesis and myeloid disorders. Bataller A; Montalban-Bravo G; Soltysiak KA; Garcia-Manero G Leukemia; 2019 May; 33(5):1076-1089. PubMed ID: 30816330 [TBL] [Abstract][Full Text] [Related]
2. Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. Zhou L; McMahon C; Bhagat T; Alencar C; Yu Y; Fazzari M; Sohal D; Heuck C; Gundabolu K; Ng C; Mo Y; Shen W; Wickrema A; Kong G; Friedman E; Sokol L; Mantzaris I; Pellagatti A; Boultwood J; Platanias LC; Steidl U; Yan L; Yingling JM; Lahn MM; List A; Bitzer M; Verma A Cancer Res; 2011 Feb; 71(3):955-63. PubMed ID: 21189329 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta signaling in normal and malignant hematopoiesis. Isufi I; Seetharam M; Zhou L; Sohal D; Opalinska J; Pahanish P; Verma A J Interferon Cytokine Res; 2007 Jul; 27(7):543-52. PubMed ID: 17651015 [TBL] [Abstract][Full Text] [Related]
5. Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes. Paracatu LC; Schuettpelz LG Front Immunol; 2020; 11():1236. PubMed ID: 32625214 [TBL] [Abstract][Full Text] [Related]
6. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566 [TBL] [Abstract][Full Text] [Related]
7. Energy metabolism and drug response in myeloid leukaemic stem cells. Bencomo-Alvarez AE; Rubio AJ; Gonzalez MA; Eiring AM Br J Haematol; 2019 Aug; 186(4):524-537. PubMed ID: 31236939 [TBL] [Abstract][Full Text] [Related]
16. Control of hematopoiesis and apoptosis in MDS: more than FLIPing the coin. Mhyre AJ; Deeg HJ Leuk Res; 2007 Jun; 31(6):747-9. PubMed ID: 17320170 [No Abstract] [Full Text] [Related]
17. Biology of the bone marrow microenvironment and myelodysplastic syndromes. Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353 [TBL] [Abstract][Full Text] [Related]
18. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome. Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028 [TBL] [Abstract][Full Text] [Related]
19. Is Myelodysplasia a Consequence of Normal Aging? Heibl S; Stauder R; Pfeilstöcker M Curr Oncol Rep; 2021 Nov; 23(12):142. PubMed ID: 34735656 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Pleyer L; Valent P; Greil R Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]